Search

Search Constraints

You searched for: Author/Creator Fløtten, Øystein

Search Results

4. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. Issue 3 (March 2021)

5. Implementation of lung cancer CT screening in the Nordic countries. (3rd October 2017)

6. Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Issue 1 (October 2015)

7. Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Issue 1 (October 2015)

8. Muscle mass and association to quality of life in non‐small cell lung cancer patients. Issue 5 (10th May 2017)

10. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. (April 2022)